Gastric cancer screening - UpToDate

Screening and surveillance of individuals at increased risk for gastric cancer in the United States (June 2025) Universal screening programs for gastric cancer (GC) exist in several countries with a high incidence of gastric cancer. Although the incidence of gastric cancer in the United States is low, some population subgroups are at elevated risk of gastric cancer but do not routinely receive GC screening. In its recent clinical practice update, the American Gastroenterological Association (AGA) recommends GC screening and surveillance with upper endoscopy in these individuals [1]. This includes those who are first-generation immigrants from regions with a high incidence of GC or have a family history of GC in a first-degree relative without a known hereditary cancer syndrome. We also suggest screening in these patients, but because the effect on cancer-related mortality is uncertain, we individualize screening decisions after discussing the potential benefits and harms with each pati

Gastric cancer screening INTRODUCTION Gastric cancer is one of the most common cancers worldwide [1]. However, there are significant differences in the incidence of gastric cancer by region [2]. The value of screening asymptomatic individuals for gastric cancer is controversial, even in areas with a relatively high incidence of gastric cancer [3]. This topic will review the screening of gastric cancer. The epidemiology, risk factors, pathology, pathogenesis, clinical features, diagnosis, and management of gastric cancer are discussed in detail separately. (See "Epidemiology of gastric…

related reading

• Early gastric cancer: Clinical features, diagnosis, and staginguptodate.com
• Early gastric cancer: Clinical features, diagnosis, and staginguptodate.com
• Gastric cancer: Pathology and molecular pathogenesisuptodate.com
• Overview of Current Concepts in Gastric Intestinal Metaplasia and Gastric Cancerncbi.nlm.nih.gov
• Risk factors for gastric canceruptodate.com
• Pathology of Gastric Intestinal Metaplasia: Clinical Implications - PMCncbi.nlm.nih.gov
• Why don’t we screen healthy people to catch diseases early? | Out-Of-Pocketoutofpocket.health
• Epidemiology and risk factors for esophageal canceruptodate.com
• Clinical presentation, diagnosis, and staging of esophageal canceruptodate.com
• Current Status of Mucosal Imaging with Narrow-Band Imaging in the Esophagusncbi.nlm.nih.gov
• Barrett's esophagus: Epidemiology, clinical manifestations, and diagnosisuptodate.com
• Barrett's esophagus: Epidemiology, clinical manifestations, and diagnosisuptodate.com